Evidence map›Paper›PMID 38785917›Full record

ArticleBiomolecules2024

Knockdown H19 Accelerated iPSCs Reprogramming through Epigenetic Modifications and Mesenchymal-to-Epithelial Transition.

Ruizhen Sun, Ximei Zhang, Tiantian Gong, Yue Zhang, Qi Wang, Chenyao He, Jielan Ju, Chunmiao Jin, Wenxin Ding, Jingnan Gao and 3 more

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. TET3 protects theiScience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ruizhen SunDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Ximei ZhangDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Tiantian GongDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Yue ZhangDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Qi WangDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Chenyao HeDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Jielan JuDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Chunmiao JinDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Wenxin DingDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Jingnan GaoDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Jingling ShenInstitute of Life Sciences, College of Life and Environmental Science, Wenzhou University, Wenzhou 325035, China.
Qiuming LiDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.
Zhiyan ShanDepartment of Histology and Embryology, Harbin Medical University, Harbin 150081, China.

Funding

National Natural Science Foundation of China 31601171National Natural Science Foundation of China 82271888Natural Science Foundation of Heilongjiang Province LH2023C103
6 · The paper itself

Abstract

H19 is an essential imprinted gene that is expressed to govern normal embryonic development. During reprogramming, the parental pronuclei have asymmetric reprogramming capacities and the critical reprogramming factors predominantly reside in the male pronucleus. After inhibiting the expression of H19 and Gtl2, androgenetic haploid ESCs (AG-haESCs) can efficiently and stably support the generation of healthy SC pups at a rate of ~20%, and double-knockout parthenogenetic haESCs can also produce efficiently. Induced pluripotent stem (iPS) cell reprogramming is thought to have a characteristic epigenetic pattern that is the reverse of its developmental potential; however, it is unclear how H19 participates in iPS cell reprogramming. Here, we showed that the expression of H19 was transiently increased during iPSC reprogramming. H19 knockdown resulted in greater reprogramming efficiency. The genes associated with pluripotency showed enhanced expression during the early reprogramming process, and the Oct4 promoter was demethylated by bisulfite genomic sequencing analysis. Moreover, expression analysis revealed that the mesenchymal master regulators associated with epithelial-to-mesenchymal transition (EMT) were downregulated during reprogramming in H19 knockdown. These findings provide functional insight into the role of H19 as a barrier to the early reprogramming process.

Indexed as

Cellular ReprogrammingEpigenesis, GeneticEpithelial-Mesenchymal TransitionInduced Pluripotent Stem CellsRNA, Long NoncodingAnimalsDNA MethylationGene Knockdown TechniquesMaleMiceH19 long non-coding RNARNA, Long Noncodingcell reprogrammingH19mesenchymal-to-epithelial transition

Identifiers

PMID38785917
PMCPMC11118134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.